In FDA petition, Pfizer blasts ‘misleading’ biosims messages from J&J, Amgen and Roche

글 내용 전체보기

Eyeing $1B annual sales, Emergent BioSolutions to buy Narcan maker Adapt for $735M

글 내용 전체보기

Gilead steals new commercial chief from Amgen to tackle big sales challenges

글 내용 전체보기

With PBMs gaining power, pharma and ad agencies zero in on payer marketing

글 내용 전체보기

Merck’s latest digital diabetes coach aims to fill education and support gaps

글 내용 전체보기

Ascend scolded—again—for estrogen drug promos in OPDP’s 4th warning this year

글 내용 전체보기

Targeting a market Big Pharma’s fleeing, Tetraphase wins FDA nod for antibiotic Xerava

글 내용 전체보기

Reality check for Hong Kong biotech IPOs as Ascletis slips

글 내용 전체보기

Targeting Alzheimer’s with a soluble toll-like receptor

글 내용 전체보기

Xenon’s epilepsy drug clears phase 1b, setting stage for trial in patients

글 내용 전체보기

Biotech boom powers analysts to $4M-a-year salaries: WSJ

글 내용 전체보기

Women’s health firm KaNDy raises $32M for menopause study

글 내용 전체보기

Urovant adds gene therapy to overactive bladder pipeline

글 내용 전체보기

Novartis constructing $92m CAR-T plant as Kymriah arrives in EU

글 내용 전체보기

Samsung BioLogics says biosimilars important to utilize growing capacity

글 내용 전체보기

AGC Bio adding 12,000L of ‘competitive and flexible’ capacity in Denmark

글 내용 전체보기

BMS Appoints New Executive Vice-President and Chief Commercial Officer

글 내용 전체보기

ABEC Expands Equipment Supply Capability

글 내용 전체보기

Solutions and Solvents Improve Analytical Instrument Performance

글 내용 전체보기

Protagen Protein Services Expands Analytical Services for Biosimilar Development

글 내용 전체보기

New Mass Spec Software Simplifies Data Analysis

글 내용 전체보기